P53 (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "P53" in Turkish language version.

Last modified: 18:17:00, 15 March 2026 (UTC)

Ref.Un. Ref.Website

Global rank Turkish rank

98web.archive.org

1^st place

88nih.gov

5^th place

8^th place

77doi.org

2^nd place

33semanticscholar.org

15^th place

461^st place

21biyorad.com

low place

11drozdogan.com

low place

biyorad.com (Global: low place; Turkish: low place)

"Arşivlenmiş kopya". 13 Nisan 2025 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Nisan 2025.

doi.org (Global: 2^nd place; Turkish: 2^nd place)

Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. (August 2009). "TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies". The Lancet. Oncology. 10 (8): 772–84. doi:10.1016/S1470-2045(09)70187-1. PMID 19625214 7 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi..
Sonoyama T, Sakai A, Mita Y, Yasuda Y, Kawamoto H, Yagi T, Yoshioka M, Mimura T, Nakachi K, Ouchida M, Yamamoto K, Shimizu K (2011). "TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers". Molecular Medicine Reports. 4 (3): 489–95. doi:10.3892/mmr.2011.449. PMID 21468597 10 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, Rafeek M, Akil N, Alkhalaf M (September 2011). "P53 gene polymorphisms and breast cancer risk in Arab women". Medical Oncology. 28 (3): 709–15. doi:10.1007/s12032-010-9505-4. PMID 20443084 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 207372095
Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG, Wei Q (September 2011). "Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.". Molecular Carcinogenesis. 50 (9): 697–706. doi:10.1002/mc.20806. PMC 3142329 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.. PMID 21656578 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, Kim YC, Oh IJ, Kim KS, Shin MH (September 2011). "p53 codon 72 polymorphism and the risk of lung cancer in a Korean population". Lung Cancer. 73 (3): 264–7. doi:10.1016/j.lungcan.2010.12.017. PMID 21316118 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC (November 2011). "TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis". Molecular Biology Reports. 38 (8): 4847–53. doi:10.1007/s11033-010-0619-8. PMID 21140221 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 11730631
Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L (December 2011). "TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis". Medical Oncology. 28 (4): 1129–35. doi:10.1007/s12032-010-9597-x. PMID 20552298 6 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 32990396

drozdogan.com (Global: low place; Turkish: low place)

https://www.drozdogan.com/tp53-geni-ve-p53-proteini-nedir-kanserde-tp53-mutasyon-pozitifligi^{[ölü/kırık bağlantı]}

nih.gov (Global: 5^th place; Turkish: 8^th place)

pubmed.ncbi.nlm.nih.gov

Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. (August 2009). "TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies". The Lancet. Oncology. 10 (8): 772–84. doi:10.1016/S1470-2045(09)70187-1. PMID 19625214 7 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi..
Sonoyama T, Sakai A, Mita Y, Yasuda Y, Kawamoto H, Yagi T, Yoshioka M, Mimura T, Nakachi K, Ouchida M, Yamamoto K, Shimizu K (2011). "TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers". Molecular Medicine Reports. 4 (3): 489–95. doi:10.3892/mmr.2011.449. PMID 21468597 10 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, Rafeek M, Akil N, Alkhalaf M (September 2011). "P53 gene polymorphisms and breast cancer risk in Arab women". Medical Oncology. 28 (3): 709–15. doi:10.1007/s12032-010-9505-4. PMID 20443084 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 207372095
Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG, Wei Q (September 2011). "Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.". Molecular Carcinogenesis. 50 (9): 697–706. doi:10.1002/mc.20806. PMC 3142329 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.. PMID 21656578 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, Kim YC, Oh IJ, Kim KS, Shin MH (September 2011). "p53 codon 72 polymorphism and the risk of lung cancer in a Korean population". Lung Cancer. 73 (3): 264–7. doi:10.1016/j.lungcan.2010.12.017. PMID 21316118 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC (November 2011). "TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis". Molecular Biology Reports. 38 (8): 4847–53. doi:10.1007/s11033-010-0619-8. PMID 21140221 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 11730631
Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L (December 2011). "TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis". Medical Oncology. 28 (4): 1129–35. doi:10.1007/s12032-010-9597-x. PMID 20552298 6 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 32990396

ncbi.nlm.nih.gov

Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG, Wei Q (September 2011). "Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.". Molecular Carcinogenesis. 50 (9): 697–706. doi:10.1002/mc.20806. PMC 3142329 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.. PMID 21656578 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.

semanticscholar.org (Global: 15^th place; Turkish: 461^st place)

api.semanticscholar.org

Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, Rafeek M, Akil N, Alkhalaf M (September 2011). "P53 gene polymorphisms and breast cancer risk in Arab women". Medical Oncology. 28 (3): 709–15. doi:10.1007/s12032-010-9505-4. PMID 20443084 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 207372095
Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC (November 2011). "TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis". Molecular Biology Reports. 38 (8): 4847–53. doi:10.1007/s11033-010-0619-8. PMID 21140221 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 11730631
Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L (December 2011). "TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis". Medical Oncology. 28 (4): 1129–35. doi:10.1007/s12032-010-9597-x. PMID 20552298 6 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 32990396

web.archive.org (Global: 1^st place; Turkish: 1^st place)

Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. (August 2009). "TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies". The Lancet. Oncology. 10 (8): 772–84. doi:10.1016/S1470-2045(09)70187-1. PMID 19625214 7 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi..
Sonoyama T, Sakai A, Mita Y, Yasuda Y, Kawamoto H, Yagi T, Yoshioka M, Mimura T, Nakachi K, Ouchida M, Yamamoto K, Shimizu K (2011). "TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers". Molecular Medicine Reports. 4 (3): 489–95. doi:10.3892/mmr.2011.449. PMID 21468597 10 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, Rafeek M, Akil N, Alkhalaf M (September 2011). "P53 gene polymorphisms and breast cancer risk in Arab women". Medical Oncology. 28 (3): 709–15. doi:10.1007/s12032-010-9505-4. PMID 20443084 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 207372095
Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG, Wei Q (September 2011). "Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.". Molecular Carcinogenesis. 50 (9): 697–706. doi:10.1002/mc.20806. PMC 3142329 14 Nisan 2024 tarihinde Wayback Machine sitesinde arşivlendi.. PMID 21656578 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, Kim YC, Oh IJ, Kim KS, Shin MH (September 2011). "p53 codon 72 polymorphism and the risk of lung cancer in a Korean population". Lung Cancer. 73 (3): 264–7. doi:10.1016/j.lungcan.2010.12.017. PMID 21316118 9 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.
Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC (November 2011). "TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis". Molecular Biology Reports. 38 (8): 4847–53. doi:10.1007/s11033-010-0619-8. PMID 21140221 8 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 11730631
Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L (December 2011). "TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis". Medical Oncology. 28 (4): 1129–35. doi:10.1007/s12032-010-9597-x. PMID 20552298 6 Şubat 2021 tarihinde Wayback Machine sitesinde arşivlendi.. S2CID 32990396
"Arşivlenmiş kopya". 13 Nisan 2025 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Nisan 2025.